AI assistant
Sending…
STANDARD BIOTOOLS INC. — Director's Dealing 2013
Nov 19, 2013
32853_dirs_2013-11-19_be3a9932-2ae7-48b7-a87f-ff7b402537db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2013-11-15
Reporting Person: Walder Fredric T (CHIEF OPERATING OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-15 | Common Stock | M | 1500 | $4.4461 | Acquired | 1500 | Direct |
| 2013-11-15 | Common Stock | S | 1500 | $30.33 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-15 | Employee Stock Option (Right to Buy) | $4.4461 | M | 1500 | Disposed | 2020-08-26 | Common Stock (1500) | Direct |
Footnotes
F1: The sales reported by Mr. Walder were effected pursuant to a Rule 10b5-1 trading plan adopted on September 13, 2013.
F2: 25% of the shares subject to the Option vested on May 17, 2011, and 1/48th of the shares subject to the Option shall vest monthly thereafter.
More from STANDARD BIOTOOLS INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 18
M&A Activity
2026
Jun 8
M&A Activity
2026
Jun 8
Regulatory Filings
2026
Jun 5
Board/Management Information
2026
Jun 3
Regulatory Filings
2026
May 29
Board/Management Information
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3